Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Reata Pharma (NQ: RETA ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Sep 25, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Reata Pharma < Previous 1 2 ... 7 8 9 10 11 12 13 14 Next > Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday December 09, 2021 Good morning, trader! It's time to kick off another busy day of trading with the biggest pre-market stock movers for Thursday! Via InvestorPlace Exposures Product Safety 21 Stocks Moving in Thursday's Pre-Market Session December 09, 2021 Gainers Pear Therapeutics, Inc. (NASDAQ: PEAR) rose 64% to $15.20 in pre-market trading after climbing around 16% on Wednesday. Ensysce Biosciences, Inc. (NASDAQ: ENSC) rose 32.2... Via Benzinga REATA ALERT: Bragar Eagel & Squire, P.C. is Investigating Reata Pharmaceuticals, Inc. on Behalf of Reata Stockholders and Encourages Investors to Contact the Firm December 08, 2021 From Bragar Eagel & Squire, P.C. Via Business Wire Reata Pharmaceuticals Announces Outcome of FDA Advisory Committee Meeting of Bardoxolone for the Treatment of Patients with Chronic Kidney Disease Caused by Alport Syndrome December 08, 2021 From Reata Pharmaceuticals, Inc. Via Business Wire The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom December 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus EyePoint Announces Commercialization Agreement For Dexycu To Treat Post-... Via Benzinga Topics Intellectual Property Lawsuit Exposures Financial Intellectual Property Legal Reata Pharmaceuticals Stock Trading Halted Today; FDA Advisory Committee to Discuss Bardoxolone for the Treatment of Patients With Chronic Kidney Disease Caused by Alport Syndrome December 08, 2021 From Reata Pharmaceuticals, Inc. Via Business Wire INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Reata Pharmaceuticals, Inc. (RETA) on Behalf of Investors December 07, 2021 From Law Offices of Howard G. Smith Via Business Wire The Law Offices of Frank R. Cruz Announces Investigation of Reata Pharmaceuticals, Inc. (RETA) on Behalf of Investors December 07, 2021 From The Law Offices of Frank R. Cruz Via Business Wire Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Reata Pharmaceuticals, Inc. (RETA) on Behalf of Investors December 06, 2021 From Glancy Prongay & Murray LLP Via Business Wire 60 Biggest Movers From Yesterday December 07, 2021 Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 200.4% to close at $15.05 on Monday after the company announced the commencement of a formal process to explore... Via Benzinga FDA Raises Concerns On Reata's Kidney Disease Drug Data; Shares Plunge December 06, 2021 Reata Pharmaceuticals Inc (NASDAQ: RETA) shares are trading lower during the market trading session after the FDA released briefing documents ahead of the Advisory... Via Benzinga Exposures Product Safety Reata Pharma Stock Dives 40% As FDA Reviewers Waffle On Kidney Disease Drug December 06, 2021 FDA experts are set to debate the drug's merits and risks on Wednesday. Via Investor's Business Daily Exposures Product Safety 12 Health Care Stocks Moving In Monday's Intraday Session December 06, 2021 Gainers Adicet Bio (NASDAQ:ACET) shares i... Via Benzinga 36 Stocks Moving In Monday's Mid-Day Session December 06, 2021 Gainers Del Taco Restaurants, Inc. (NASDAQ: TACO) shares jumped 64.6% to $12.40. Jack In The Box Inc (NASDAQ: JACK) agreed to acquire Del Taco Restaurants for $12.51 per share... Via Benzinga Mid-Morning Market Update: Markets Mostly Higher; Science Applications International Posts Upbeat Earnings December 06, 2021 Following the market opening Monday, the Dow traded up 1.35% to 35,048.01 while the NASDAQ fell 0.17% to 15,059.43. The S&P also rose, gaining 0.59% to 4,565.21. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More December 06, 2021 The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative... Via Benzinga Exposures Product Safety Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates December 02, 2021 A majority of verdicts handed down by the FDA in November were positive. Three new molecular entities were approved during the month, taking the total number of NME approvals for... Via Benzinga Exposures Product Safety The Daily Biotech Pulse: Connect Biopharma Sinks On Eczema Drug Readout, Enanta Pulls Plug On HBV Drug, Clinical Setback For Merck In HIV Trial November 19, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Connect Biopharma Atopic Dermatitis Treatment Aces Mid-stage Study But Lack... Via Benzinga Reata Pharmaceuticals Receives Fast Track Designation From the FDA for Omaveloxolone for the Treatment of Friedreich’s Ataxia November 18, 2021 From Reata Pharmaceuticals, Inc. Via Business Wire Reata Pharmaceuticals, inc (RETA) Q3 2021 Earnings Call Transcript November 08, 2021 RETA earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Reata Pharmaceuticals's Return On Capital Employed Overview November 08, 2021 According to Benzinga Pro data, during Q3, Reata Pharmaceuticals (NASDAQ:RETA) posted sales of $7.39 million. Earnings were up 3.38%, but Reata Pharmaceuticals still reported an... Via Benzinga The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More November 08, 2021 Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out... Via Benzinga Reata Pharmaceuticals: Q3 Earnings Insights November 08, 2021 Reata Pharmaceuticals (NASDAQ:RETA) reported its Q3 earnings results on Monday, November 8, 2021 at 08:00 AM. Here's what investors need to know about the announcement... Via Benzinga Reata Pharmaceuticals, Inc. Announces Third Quarter 2021 Financial Results and Provides an Update on Clinical Development Programs November 08, 2021 From Reata Pharmaceuticals, Inc. Via Business Wire A Preview Of Reata Pharmaceuticals's Earnings November 05, 2021 Reata Pharmaceuticals (NASDAQ:RETA) is set to give its latest quarterly earnings report on Monday, 2021-11-08. Here's what investors need to know before the announcement. Analysts... Via Benzinga Reata Pharmaceuticals, Inc. to Report Third Quarter 2021 Financial Results and to Provide an Update on Development Programs on November 8, 2021 November 01, 2021 From Reata Pharmaceuticals, Inc. Via Business Wire The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs October 29, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Gilead, Merck to Study Trodelvy-Keytruda Combo For Breast Cancer Gilead, Inc... Via Benzinga Earnings Scheduled For November 8, 2021 November 08, 2021 Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •... Via Benzinga Reata Pharmaceuticals Submits Marketing Authorization Application to the European Medicines Agency for Bardoxolone Methyl in Chronic Kidney Disease Caused by Alport Syndrome October 28, 2021 From Reata Pharmaceuticals, Inc. Via Business Wire Reata Pharmaceuticals Announces Presentations at the American Society of Nephrology Kidney Week 2021 October 15, 2021 From Reata Pharmaceuticals, Inc. Via Business Wire < Previous 1 2 ... 7 8 9 10 11 12 13 14 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
